Welcome to our dedicated page for Encompass Health Corporation news (Ticker: EHC), a resource for investors and traders seeking the latest updates and insights on Encompass Health Corporation stock.
Encompass Health Corporation (NYSE: EHC) is a leading provider of post-acute healthcare services in the United States. Specializing in inpatient rehabilitation, the company operates a network of 161 hospitals across 37 states and Puerto Rico. These hospitals offer comprehensive rehabilitative care for patients recovering from major injuries and illnesses, including strokes, brain injuries, spinal cord injuries, and complex orthopedic conditions.
Encompass Health's business model revolves around delivering high-quality, cost-effective care through both facility-based and home-based patient care. The company's integrated approach includes advanced therapies, customized treatment plans, and coordinated care teams to ensure optimal patient outcomes. Their commitment to excellence is reflected in their significant market presence and continual expansion. Recent projects include new inpatient rehabilitation hospitals in Avondale, Arizona, and San Antonio, Texas, aimed at enhancing their service offerings.
Financially, Encompass Health has demonstrated robust performance with consistent revenue growth. For instance, the company reported a 13.4% revenue growth in Q1 2024, driven by strong discharge growth and efficient expense management, leading to an Adjusted EBITDA growth of 19.2%. Their strategic focus on improving labor costs and operational efficiency continues to bolster their financial health.
Encompass Health's dedication to innovation is evident in their use of advanced rehabilitation technologies and their commitment to ongoing research. The company recently announced a call for research grant applications, aimed at investigating the effectiveness of therapies in post-acute care settings. This initiative underscores their commitment to enhancing patient care through evidence-based practices.
Recognized as one of Fortune's World's Most Admired Companies and Modern Healthcare's Best Places to Work in Healthcare, Encompass Health prioritizes a positive working environment for its staff, ensuring they are equipped with the necessary tools and support to deliver exceptional patient care.
For the latest updates on Encompass Health Corporation, including their quarterly earnings reports, new hospital developments, and research initiatives, visit their investor website or follow their official social media channels.
Encompass Health Corporation (NYSE: EHC) reported Q2 2022 results reflecting a 3.3% increase in net operating revenues to $1,330.5 million. However, income per share from continuing operations dropped 56.6% to $0.49. Discharge growth was 4.9%, complementing an 18.7% growth in Q2 2021. The company faced staffing challenges impacting Adjusted EBITDA, which decreased by 13.9% to $240.2 million. Despite this, full-year 2022 guidance remains intact, expecting net revenues between $4,250 million and $4,300 million.
On July 20, 2022, Encompass Health Corporation (NYSE: EHC) announced a quarterly cash dividend of $0.15 per share, payable on October 17, 2022, to shareholders on record by October 3, 2022. This dividend follows the recent spin-off of Enhabit Home Health & Hospice and underscores the company's commitment to expanding its rehabilitation services, with plans to open 9 new rehabilitation hospitals this year and a similar number in 2023.
Encompass Health Corp. (NYSE: EHC) and BJC HealthCare have received a certificate of need to establish a freestanding 40-bed inpatient rehabilitation hospital in Town and Country, Missouri, anticipated to open in 2024. This facility will be a satellite of The Rehabilitation Institute of St. Louis and will relocate BJC's existing rehabilitation unit. The new hospital aims to enhance rehabilitation services, offering various therapies and round-the-clock nursing care to patients recovering from serious conditions.
Encompass Health Corp. (NYSE: EHC) will release its second quarter results for the period ended June 30, 2022, on August 1, 2022, after market close. An investor conference call is scheduled for August 2, 2022, at 10 a.m. ET to discuss the results. The call can be accessed by dialing 866-342-8591 for domestic callers and 203-518-9713 for international callers. Encompass Health is the largest operator of rehabilitation hospitals in the U.S., with 150 hospitals across 35 states and Puerto Rico.
Encompass Health Corporation has successfully completed the spin-off of its home health and hospice business, Enhabit, Inc., as of July 1, 2022. Each Encompass Health stockholder received one share of Enhabit common stock for every two shares held by the close of business on June 24, 2022. This transaction is structured to be tax-free for shareholders, except for cash received for fractional shares. Enhabit will begin trading on the NYSE under the symbol 'EHAB,' while Encompass Health continues to trade under 'EHC.'
Encompass Health Corp. (NYSE: EHC) and NCH Healthcare System are forming a joint venture to create a 50-bed inpatient rehabilitation hospital in Naples, Florida, set to open in August 2022. This new facility will enhance rehabilitation services in the region by relocating NCH's existing 54-bed rehabilitation unit there. Both organizations emphasize their commitment to patient care, with Encompass Health being a leading provider of rehabilitation services and NCH known for quality healthcare in Collier County. The partnership aims to improve patient outcomes and expand service offerings.
Encompass Health Corporation (EHC) declared a distribution of all outstanding shares of its subsidiary, Enhabit, Inc., to its stockholders. The record date for this spin-off is June 24, 2022, with the distribution expected to complete on July 1, 2022. Stockholders will receive one share of Enhabit common stock for every two shares of Encompass Health held. The transaction is intended to be tax-free for U.S. federal income tax purposes, except for cash received for fractional shares. Encompass Health will continue to trade under the ticker EHC, while Enhabit will trade as EHAB.
Encompass Health Corporation (NYSE: EHC) announced separate full-year 2022 guidance for its inpatient rehabilitation business and its home health and hospice business (Enhabit). The company plans to spin off Enhabit on July 1, 2022, subject to regulatory approvals. Updated guidance includes consolidated net operating revenues of $5,330 to $5,420 million, adjusted EBITDA of $1,005 to $1,045 million, and adjusted earnings per share from continuing operations of $3.76 to $4.05. Key factors include Medicare pricing adjustments and anticipated operational improvements in the second half of 2022.
Encompass Health Corp. (NYSE: EHC) has opened the Encompass Health Rehabilitation Hospital of Cape Coral, a state-of-the-art 40-bed inpatient facility in Florida. This hospital features all private patient rooms, advanced rehabilitation technologies, and specialized nursing, therapy, and medical services aimed at helping patients recover from serious conditions like strokes and spinal cord injuries. The Cape Coral facility is the 149th hospital for Encompass Health and the 17th in Florida, with plans for two more hospitals to open in the state later this year.
FAQ
What is the current stock price of Encompass Health Corporation (EHC)?
What is the market cap of Encompass Health Corporation (EHC)?
What services does Encompass Health Corporation provide?
How many hospitals does Encompass Health operate?
What conditions do Encompass Health hospitals treat?
What recent developments have been made by Encompass Health?
How did Encompass Health perform financially in Q1 2024?
What recognitions has Encompass Health received?
How does Encompass Health support its employees?
Where can I find the latest news about Encompass Health?
What initiatives does Encompass Health have for research?
What technologies does Encompass Health use in rehabilitation?
